Healthy Subjects Clinical Trial
Official title:
Effect of Avocado Honey (Apis Mellifera) on Anthropometric and Biochemical Parameters in Healthy Subjects: A Pilot Study
Verified date | October 2020 |
Source | Universidad Autonoma de Nuevo Leon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Thirteen healthy subjects (5 males; 8 females) ages 25-50 years, with BMI (body mass index): <25 kg/m2 completed the study. The participants were selected randomly, either the control group (n= 7) or honey group (n= 6). Subjects of honey group consumed 25 g of honey each day for 4 weeks.
Status | Completed |
Enrollment | 13 |
Est. completion date | July 18, 2020 |
Est. primary completion date | July 12, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 25 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Male - Female - Ages 25-50 years, - BMI (body mass index): under 25 kg per m2. Exclusion Criteria: - Not smoker - Not have an allergy to honey - Not pregnant, - Not been previously diagnosed any disease resulting in metabolic disorders - Not chronically use medications known to affect metabolism - Not participate in greater than 3 hours of structured exercise per week. - Female participants that used some kind of contraceptives |
Country | Name | City | State |
---|---|---|---|
Mexico | Facultad de Salud Publica y Nutricion | Monterrey | Nuevo Leon |
Lead Sponsor | Collaborator |
---|---|
Universidad Autonoma de Nuevo Leon |
Mexico,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Subject numbers that experienced a change of glucose level (mg/dL) post-intake of 25 g/day of honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of triglycerides levels (mg/dL) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of total cholesterol levels (mg/dL) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of HDL-cholesterol levels (mg/dL) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of LDL-cholesterol levels (mg/dL) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of body weight (kg) post-intake of 25 g/day honey. | Frame: from the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of body fat (%) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of waist circumference (cm) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of hip circumference (cm) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of waist-hip ratio post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks | ||
Primary | Subject numbers that experienced change of BMI (weight (kg)/height (m)2) post-intake of 25 g/day honey | From the start of treatment (baseline) until 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05483998 -
A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT02417714 -
Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
|
||
Recruiting |
NCT02235012 -
Cognitive Biases Under Ketamine
|
N/A | |
Completed |
NCT04418973 -
Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject.
|
N/A | |
Completed |
NCT05088343 -
Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06248801 -
Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets
|
Phase 1 | |
Terminated |
NCT04068259 -
Single Ascending Dose Study of PBI-4547 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03279302 -
Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects
|
Phase 1 | |
Not yet recruiting |
NCT06233162 -
Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets
|
Phase 1 | |
Recruiting |
NCT04159844 -
Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects
|
N/A | |
Completed |
NCT06137911 -
Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults.
|
Phase 1 | |
Completed |
NCT04849286 -
Measurement of HTL0016878 in Cerebrospinal Fluid
|
Phase 1 | |
Not yet recruiting |
NCT06233227 -
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
|
Phase 1 | |
Completed |
NCT04096157 -
A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants
|
Phase 1 | |
Completed |
NCT01200368 -
Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants
|
Phase 3 | |
Recruiting |
NCT05805033 -
Peri-Implant Soft Tissue Integration in Humans: Influence of Material
|
N/A | |
Completed |
NCT04027803 -
Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris®
|
Phase 1 | |
Recruiting |
NCT03467880 -
Multicenter Study of Impulse Oscillometry in Chinese
|
N/A | |
Completed |
NCT02903095 -
Single Ascending Dose Study of TD-1439 in Healthy Subjects
|
Phase 1 | |
Active, not recruiting |
NCT02341508 -
A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers
|
Phase 1 |